Cargando…

Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload

Progressive cardiac fibrosis accelerates the development of heart failure. Here, we aimed to explore serum Wnt5a and Wnt11 levels in hypertension patients, the roles of Wnt5a and Wnt11 in cardiac fibrosis and potential mechanisms under pressure overload. The pressure overload mouse model was built b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yan, Pan, Le, Shen, Yi, Wang, Xiang, Huang, Chenxing, Wang, Hao, Jin, Xuejuan, Yin, Chao, Wang, Ying, Jia, Jianguo, Qian, Juying, Zou, Yunzeng, Gong, Hui, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464604/
https://www.ncbi.nlm.nih.gov/pubmed/34564708
http://dx.doi.org/10.1038/s41419-021-04152-2
_version_ 1784572664196628480
author Zou, Yan
Pan, Le
Shen, Yi
Wang, Xiang
Huang, Chenxing
Wang, Hao
Jin, Xuejuan
Yin, Chao
Wang, Ying
Jia, Jianguo
Qian, Juying
Zou, Yunzeng
Gong, Hui
Ge, Junbo
author_facet Zou, Yan
Pan, Le
Shen, Yi
Wang, Xiang
Huang, Chenxing
Wang, Hao
Jin, Xuejuan
Yin, Chao
Wang, Ying
Jia, Jianguo
Qian, Juying
Zou, Yunzeng
Gong, Hui
Ge, Junbo
author_sort Zou, Yan
collection PubMed
description Progressive cardiac fibrosis accelerates the development of heart failure. Here, we aimed to explore serum Wnt5a and Wnt11 levels in hypertension patients, the roles of Wnt5a and Wnt11 in cardiac fibrosis and potential mechanisms under pressure overload. The pressure overload mouse model was built by transverse aortic constriction (TAC). Cardiac fibrosis was analyzed by Masson’s staining. Serum Wnt5a or Wnt11 was elevated and associated with diastolic dysfunction in hypertension patients. TAC enhanced the expression and secretion of Wnt5a or Wnt11 from cardiomyocytes (CMs), cardiac fibroblasts (CFs), and cardiac microvascular endothelial cells (CMECs). Knockdown of Wnt5a and Wnt11 greatly improved cardiac fibrosis and function at 4 weeks after TAC. In vitro, shWnt5a or shWnt11 lentivirus transfection inhibited pro-fibrotic effects in CFs under mechanical stretch (MS). Similarly, conditional medium from stretched-CMs transfected with shWnt5a or shWnt11 lentivirus significantly suppressed the pro-fibrotic effects induced by conditional medium from stretched-CMs. These data suggested that CMs- or CFs-derived Wnt5a or Wnt11 showed a pro-fibrotic effect under pressure overload. In vitro, exogenous Wnt5a or Wnt11 activated ERK and p38 (fibrotic-related signaling) pathway, promoted the phosphorylation of EGFR, and increased the expression of Frizzled 5 (FZD5) in CFs. Inhibition or knockdown of EGFR greatly attenuated the increased FZD5, p-p38, and p-ERK levels, and the pro-fibrotic effect induced by Wnt5a or Wnt11 in CFs. Si-FZD5 transfection suppressed the increased p-EGFR level, and the fibrotic-related effects in CFs treated with Wnt5a or Wnt11. In conclusion, pressure overload enhances the secretion of Wnt5a or Wnt11 from CMs and CFs which promotes cardiac fibrosis by activation the crosstalk of FZD5 and EGFR. Thus, Wnt5a or Wnt11 may be a novel therapeutic target for the prevention of cardiac fibrosis under pressure overload.
format Online
Article
Text
id pubmed-8464604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84646042021-10-08 Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload Zou, Yan Pan, Le Shen, Yi Wang, Xiang Huang, Chenxing Wang, Hao Jin, Xuejuan Yin, Chao Wang, Ying Jia, Jianguo Qian, Juying Zou, Yunzeng Gong, Hui Ge, Junbo Cell Death Dis Article Progressive cardiac fibrosis accelerates the development of heart failure. Here, we aimed to explore serum Wnt5a and Wnt11 levels in hypertension patients, the roles of Wnt5a and Wnt11 in cardiac fibrosis and potential mechanisms under pressure overload. The pressure overload mouse model was built by transverse aortic constriction (TAC). Cardiac fibrosis was analyzed by Masson’s staining. Serum Wnt5a or Wnt11 was elevated and associated with diastolic dysfunction in hypertension patients. TAC enhanced the expression and secretion of Wnt5a or Wnt11 from cardiomyocytes (CMs), cardiac fibroblasts (CFs), and cardiac microvascular endothelial cells (CMECs). Knockdown of Wnt5a and Wnt11 greatly improved cardiac fibrosis and function at 4 weeks after TAC. In vitro, shWnt5a or shWnt11 lentivirus transfection inhibited pro-fibrotic effects in CFs under mechanical stretch (MS). Similarly, conditional medium from stretched-CMs transfected with shWnt5a or shWnt11 lentivirus significantly suppressed the pro-fibrotic effects induced by conditional medium from stretched-CMs. These data suggested that CMs- or CFs-derived Wnt5a or Wnt11 showed a pro-fibrotic effect under pressure overload. In vitro, exogenous Wnt5a or Wnt11 activated ERK and p38 (fibrotic-related signaling) pathway, promoted the phosphorylation of EGFR, and increased the expression of Frizzled 5 (FZD5) in CFs. Inhibition or knockdown of EGFR greatly attenuated the increased FZD5, p-p38, and p-ERK levels, and the pro-fibrotic effect induced by Wnt5a or Wnt11 in CFs. Si-FZD5 transfection suppressed the increased p-EGFR level, and the fibrotic-related effects in CFs treated with Wnt5a or Wnt11. In conclusion, pressure overload enhances the secretion of Wnt5a or Wnt11 from CMs and CFs which promotes cardiac fibrosis by activation the crosstalk of FZD5 and EGFR. Thus, Wnt5a or Wnt11 may be a novel therapeutic target for the prevention of cardiac fibrosis under pressure overload. Nature Publishing Group UK 2021-09-25 /pmc/articles/PMC8464604/ /pubmed/34564708 http://dx.doi.org/10.1038/s41419-021-04152-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zou, Yan
Pan, Le
Shen, Yi
Wang, Xiang
Huang, Chenxing
Wang, Hao
Jin, Xuejuan
Yin, Chao
Wang, Ying
Jia, Jianguo
Qian, Juying
Zou, Yunzeng
Gong, Hui
Ge, Junbo
Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
title Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
title_full Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
title_fullStr Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
title_full_unstemmed Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
title_short Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
title_sort cardiac wnt5a and wnt11 promote fibrosis by the crosstalk of fzd5 and egfr signaling under pressure overload
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464604/
https://www.ncbi.nlm.nih.gov/pubmed/34564708
http://dx.doi.org/10.1038/s41419-021-04152-2
work_keys_str_mv AT zouyan cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT panle cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT shenyi cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT wangxiang cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT huangchenxing cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT wanghao cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT jinxuejuan cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT yinchao cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT wangying cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT jiajianguo cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT qianjuying cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT zouyunzeng cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT gonghui cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload
AT gejunbo cardiacwnt5aandwnt11promotefibrosisbythecrosstalkoffzd5andegfrsignalingunderpressureoverload